Antibodies Induced by Homologous or Heterologous Inactivated (CoronaVac/BBIBP-CorV) and Recombinant Protein Subunit Vaccines (ZF2001) Dramatically Enhanced Inhibitory Abilities against B.1.351, B.1.617.2, and B.1.1.529 Variants

Safe and effective vaccines for Corona Virus Disease 2019 (COVID-19) can prevent the virus from infecting human populations and treat patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In this study, we discuss the inhibitory abilities of primary and booster vaccine...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Xuesong, Hong, Yi, Chen, Erjing, Wang, Yaping, Ma, Biao, Li, Jiali, Su, Wei, Zhou, Yuxin, Zhang, Mingzhou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9782763/
https://www.ncbi.nlm.nih.gov/pubmed/36560520
http://dx.doi.org/10.3390/vaccines10122110

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9782763/
https://www.ncbi.nlm.nih.gov/pubmed/36560520
http://dx.doi.org/10.3390/vaccines10122110

Ejemplares similares